Neurocrine Biosciences NBIX
NASDAQ NBIX
$141.84 +3.49 (+2.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

Neurocrine Biosciences (NBIX) Other financing activities (2026)

Updated

Neurocrine Biosciences' Other financing activities was $2.7 million in Q2 2026, down 95.2% from the prior quarter.

Analysis

Neurocrine Biosciences (NBIX) Other financing activities (2026) Analysis & Trends

On a trailing twelve-month basis, Neurocrine Biosciences' Other financing activities was $58.4 million through Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Neurocrine Biosciences 14.41 Bn 10.11 Bn 935.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.70 Mn
Mar 31, 2026 55.70 Mn
API Access

Neurocrine Biosciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=NBIX&period=max&api_key=YOUR_API_KEY